1BIANCO AR,BONO A,TAFFAIOLI RV,et al.Treatment of advanced prostatic carcinoma with the LHRH agonist ICI-118630 (Zoladex):results of a multicentric study[abstract][J].J Endocrinol Invest,1987,10 (Suppl 2):S21.
2METZ R,NAMER M,ADENIS L,et al.Zoladex as primary therapy in advanced prostatic cancer.A French cooperative trial[J].Am J Clin Oncol,1988,11 (Suppl 2):S112-S114.
3CHODAK GW.Luteinizing hormone-releasing hormone (LHRH) agonists for treatment of advanced prostatic carcinoma[J].Urology,1989,33 (5 Suppl):S42-S44.
4RYAN PG,PEELING WB.trials of treatment for M1 prostatic cancer.The LHRH analogue Zoladex vs.Orchidectony[J].Am J Clin Oncol,1988,11 (Suppl 2):S169-S172.
5KAISARY AV,TYRRELL CJ,PEELING WB,et al.Comparison of LHRH analogue(Zoladex)with orchiectomy in patients with metastatic carcinoma[J].Br J Urol,1991,67 (5):502-508.
7S. Eriksson,A. Eriksson,R. Stege,K. Carlstr?m. Bone mineral density in patients with prostatic cancer treated with orchidectomy and with estrogens[J] 1995,Calcified Tissue International(2):97～99
